Table of Contents

April 1, 2020; Volume 61,Issue 4

  1. Ahuja, Sukhjeet

    1. Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
      Hossein Jadvar, Leslie K. Ballas, Peter L. Choyke, Stefano Fanti, James L. Gulley, Ken Herrmann, Thomas A. Hope, Alan K. Klitzke, Jorge D. Oldan, Martin G. Pomper, Steven P. Rowe, Rathan M. Subramaniam, Samir S. Taneja, Herbert Alberto Vargas and Sukhjeet Ahuja
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 552-562; DOI: https://doi.org/10.2967/jnumed.119.240929

  2. Aparici, Carina Mari

    1. Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
      Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon and Andrei Iagaru
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 546-551; DOI: https://doi.org/10.2967/jnumed.119.231654
    2. Comparison of 3 Interpretation Criteria for 68Ga-PSMA11 PET Based on Inter- and Intrareader Agreement
      Akira Toriihara, Tomomi Nobashi, Lucia Baratto, Heying Duan, Farshad Moradi, Sonya Park, Negin Hatami, Carina Mari Aparici, Guido Davidzon and Andrei Iagaru
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 533-539; DOI: https://doi.org/10.2967/jnumed.119.232504

  3. Attili, Bala

    1. TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
      Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht, Michel Koole, Bala Attili, Sofie Celen, Lieven Declercq, Dietmar R. Thal, Philip Van Damme, Guy Bormans and Koen Van Laere
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 604-607; DOI: https://doi.org/10.2967/jnumed.119.231985

  4. Ballas, Leslie K.

    1. Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
      Hossein Jadvar, Leslie K. Ballas, Peter L. Choyke, Stefano Fanti, James L. Gulley, Ken Herrmann, Thomas A. Hope, Alan K. Klitzke, Jorge D. Oldan, Martin G. Pomper, Steven P. Rowe, Rathan M. Subramaniam, Samir S. Taneja, Herbert Alberto Vargas and Sukhjeet Ahuja
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 552-562; DOI: https://doi.org/10.2967/jnumed.119.240929

  5. Bankstahl, Marion

    1. Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure
      Aylina Glasenapp, Katja Derlin, Yong Wang, Marion Bankstahl, Martin Meier, Kai C. Wollert, Frank M. Bengel and James T. Thackeray
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 590-596; DOI: https://doi.org/10.2967/jnumed.119.232488

  6. Baratto, Lucia

    1. Comparison of 3 Interpretation Criteria for 68Ga-PSMA11 PET Based on Inter- and Intrareader Agreement
      Akira Toriihara, Tomomi Nobashi, Lucia Baratto, Heying Duan, Farshad Moradi, Sonya Park, Negin Hatami, Carina Mari Aparici, Guido Davidzon and Andrei Iagaru
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 533-539; DOI: https://doi.org/10.2967/jnumed.119.232504

  7. Barker, Christopher A.

    1. First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
      Neeta Pandit-Taskar, Michael A. Postow, Matthew D. Hellmann, James J. Harding, Christopher A. Barker, Joseph A. O’Donoghue, Martha Ziolkowska, Shutian Ruan, Serge K. Lyashchenko, Frank Tsai, Michael Farwell, Tara C. Mitchell, Ron Korn, William Le, Jason S. Lewis, Wolfgang A. Weber, Deepak Behera, Ian Wilson, Michael Gordon, Anna M. Wu and Jedd D. Wolchok
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 512-519; DOI: https://doi.org/10.2967/jnumed.119.229781

  8. Bastiaannet, Remco

    1. First Evidence for a Dose–Response Relationship in Patients Treated with 166Ho Radioembolization: A Prospective Study
      Remco Bastiaannet, Caren van Roekel, Maarten L.J. Smits, Sjoerd G. Elias, Wouter A.C. van Amsterdam, Dan Doan, Jip F. Prince, Rutger C.G. Bruijnen, Hugo W.A.M. de Jong and Marnix G.E.H. Lam
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 608-612; DOI: https://doi.org/10.2967/jnumed.119.232751

  9. Behe, Martin

    1. Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study
      Christof Rottenburger, Guillaume P. Nicolas, Lisa McDougall, Felix Kaul, Michal Cachovan, A. Hans Vija, Roger Schibli, Susanne Geistlich, Anne Schumann, Tilman Rau, Katharina Glatz, Martin Behe, Emanuel R. Christ and Damian Wild
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 520-526; DOI: https://doi.org/10.2967/jnumed.119.233031

  10. Behera, Deepak

    1. First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
      Neeta Pandit-Taskar, Michael A. Postow, Matthew D. Hellmann, James J. Harding, Christopher A. Barker, Joseph A. O’Donoghue, Martha Ziolkowska, Shutian Ruan, Serge K. Lyashchenko, Frank Tsai, Michael Farwell, Tara C. Mitchell, Ron Korn, William Le, Jason S. Lewis, Wolfgang A. Weber, Deepak Behera, Ian Wilson, Michael Gordon, Anna M. Wu and Jedd D. Wolchok
      Journal of Nuclear Medicine April 1, 2020, 61 (4) 512-519; DOI: https://doi.org/10.2967/jnumed.119.229781
« Previous (Pages : 1 2 3 4 5 6 ... 23) Next »
Back to top

In this issue